Trials / Completed
CompletedNCT05836532
Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Michele De Bonis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Mitral regurgitation is a pathology affecting the left atrioventricular valve that causes a volumetric and pressure overload in the left chambers due to the loss of unidirectionality normally guaranteed by the cardiac valve system. The gold standard for severe mitral regurgitation is currently mitral valve plastic surgery. Edge to edge, on the other hand, allows shorter CEC and aortic clamping times and does not require significant surgical experience in the field of mitral valve repair, therefore edge to edge could be an excellent strategy in patients suffering from mitral regurgitation caused by P2 prolapse when quadrangular resection cannot be performed. The main objective of the present study is to examine the medium to long-term outcomes (in terms of survival and plastic outcomes) of patients undergoing central edge-to-edge to treat posterior flap pathology (P2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Central edge-to-edge | Suture of free margins of the mitral leaflets in central position to restore coaptation |
Timeline
- Start date
- 2019-10-05
- Primary completion
- 2019-10-15
- Completion
- 2019-10-15
- First posted
- 2023-05-01
- Last updated
- 2023-05-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05836532. Inclusion in this directory is not an endorsement.